Latest Insider Transactions at Checkpoint Therapeutics, Inc. (CKPT)
This section provides a real-time view of insider transactions for Checkpoint Therapeutics, Inc. (CKPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Checkpoint Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Checkpoint Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
146,341
+3.77%
|
-
|
|
Jun 26
2024
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,038
-1.9%
|
$26,076
$2.06 P/Share
|
|
Jun 26
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Bona fide gift
|
Direct |
37,890
-1.92%
|
-
|
|
Jun 26
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
24,610
-1.23%
|
$49,220
$2.05 P/Share
|
|
May 24
2024
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,660,000
+45.33%
|
-
|
|
May 24
2024
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
540,000
+44.07%
|
-
|
|
May 14
2024
|
Sharma Amit Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,051
+28.09%
|
-
|
|
May 14
2024
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
82,051
+32.42%
|
-
|
|
May 14
2024
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.79%
|
-
|
|
May 14
2024
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.11%
|
-
|
|
May 14
2024
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+27.75%
|
-
|
|
May 14
2024
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
82,051
+31.11%
|
-
|
|
Mar 20
2024
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
193,905
+8.47%
|
-
|
|
Feb 28
2024
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,035
-1.38%
|
$4,070
$2.07 P/Share
|
|
Feb 28
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Bona fide gift
|
Direct |
9,056
-2.58%
|
-
|
|
Feb 28
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
5,894
-1.65%
|
$11,788
$2.06 P/Share
|
|
Feb 01
2024
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,115
-2.72%
|
$4,115
$1.95 P/Share
|
|
Feb 01
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Bona fide gift
|
Direct |
12,950
-3.5%
|
-
|
|
Feb 01
2024
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
11,900
-3.12%
|
$23,800
$2.01 P/Share
|
|
Dec 29
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
158,134
+7.67%
|
-
|
|
Sep 25
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
80,906
+4.43%
|
-
|
|
Jun 30
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
81,406
+4.67%
|
-
|
|
Jun 13
2023
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,483
+34.99%
|
-
|
|
Jun 13
2023
|
Scott Boilen Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,483
+31.89%
|
-
|
|
Jun 13
2023
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,483
+33.23%
|
-
|
|
Jun 13
2023
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,483
+25.86%
|
-
|
|
Jun 13
2023
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,483
+33.23%
|
-
|
|
Jun 13
2023
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
17,483
+36.72%
|
-
|
|
Apr 04
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+2.62%
|
-
|
|
Mar 31
2023
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+39.78%
|
-
|
|
Mar 31
2023
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+38.81%
|
-
|
|
Mar 31
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
35,714
+2.27%
|
-
|
|
Mar 02
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,591
-6.53%
|
$17,955
$5.0 P/Share
|
|
Mar 02
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
5,483
-3.67%
|
$27,415
$5.0 P/Share
|
|
Feb 27
2023
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+12.01%
|
-
|
|
Feb 27
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,914
-3.88%
|
$7,656
$4.66 P/Share
|
|
Feb 27
2023
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+9.11%
|
-
|
|
Feb 27
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
5,548
-3.96%
|
$22,192
$4.65 P/Share
|
|
Feb 01
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
10,261
-5.33%
|
$41,044
$4.77 P/Share
|
|
Feb 01
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,154
-6.0%
|
$12,616
$4.79 P/Share
|
|
Jan 10
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
3,817
-1.95%
|
$22,902
$6.75 P/Share
|
|
Jan 10
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,858
-3.42%
|
$11,148
$6.75 P/Share
|
|
Jan 05
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
368,907
+19.7%
|
-
|
|
Jun 23
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
15,000
-0.58%
|
$15,000
$1.11 P/Share
|
|
Jun 22
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
12,000
-0.46%
|
$12,000
$1.09 P/Share
|
|
Jun 21
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
21,000
-0.8%
|
$21,000
$1.09 P/Share
|
|
Jun 17
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
228,000
-8.03%
|
$228,000
$1.09 P/Share
|
|
Jun 16
2022
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
47,619
+27.36%
|
-
|
|
Jun 16
2022
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+21.26%
|
-
|
|
Jun 16
2022
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+12.73%
|
-
|